98 related articles for article (PubMed ID: 1336720)
1. The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4--an immunohistochemical study.
de Jong EM; van Erp PE; van Vlijmen IM; van de Kerkhof PC
Clin Exp Dermatol; 1992 Nov; 17(6):413-20. PubMed ID: 1336720
[TBL] [Abstract][Full Text] [Related]
2. The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).
van Pelt JP; de Jong EM; van Erp PE; Mitchell MI; Marder P; Spaethe SM; van Hooijdonk CA; Kuijpers AL; van de Kerkhof PC
Biochem Pharmacol; 1997 Apr; 53(7):1005-12. PubMed ID: 9174114
[TBL] [Abstract][Full Text] [Related]
3. Application of leukotriene B4 and reflectance confocal microscopy as a noninvasive in vivo model to study the dynamics of skin inflammation.
Peppelman M; Wolberink EA; Gerritsen MJ; van de Kerkhof PC; van Erp PE
Skin Res Technol; 2015 May; 21(2):232-40. PubMed ID: 25156913
[TBL] [Abstract][Full Text] [Related]
4. Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions.
Seyger MM; van Pelt JP; van den Born J; Latijnhouwers MA; de Jong EM
Arch Dermatol Res; 1997 May; 289(6):331-6. PubMed ID: 9209678
[TBL] [Abstract][Full Text] [Related]
5. Topical application of dithranol on normal skin induces epidermal hyperproliferation and increased Ks8.12 binding.
de Zwart AJ; de Jong EM; van de Kerkhof PC
Skin Pharmacol; 1992; 5(1):34-40. PubMed ID: 1374264
[TBL] [Abstract][Full Text] [Related]
6. The dynamics of the response of normal skin to single and multiple epicutaneous leukotriene B4 applications analysed by three-colour flow cytometry.
Glade CP; Botermans RJ; van Erp PE; van de Kerkhof PC
Acta Derm Venereol; 1995 Nov; 75(6):437-41. PubMed ID: 8651019
[TBL] [Abstract][Full Text] [Related]
7. An ultrastructural study of the response of normal skin to epicutaneous application of leukotriene B4.
van de Kerkhof PC; Peereboom-Stegeman JH; Boeijen J
J Dermatol; 1991 May; 18(5):271-6. PubMed ID: 1658100
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene B₄-leukotriene B₄ receptor axis promotes oxazolone-induced contact dermatitis by directing skin homing of neutrophils and CD8⁺ T cells.
Lv J; Zou L; Zhao L; Yang W; Xiong Y; Li B; He R
Immunology; 2015 Sep; 146(1):50-8. PubMed ID: 25959240
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous application of leukotriene B4 as an in vivo model of psoriasis-like skin inflammation: an immunohistological study.
Hendriks AG; Keijsers RR; Seyger MM; van de Kerkhof PC; van Erp PE
Skin Pharmacol Physiol; 2014; 27(3):120-6. PubMed ID: 24401330
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous assessment of inflammation and epidermal proliferation in psoriatic plaques during long-term treatment with the vitamin D3 analogue MC903: modulations and interrelations.
de Jong EM; van de Kerkhof PC
Br J Dermatol; 1991 Mar; 124(3):221-9. PubMed ID: 2018728
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological effects of a specific leukotriene B(4) receptor antagonist (VML 295) on blood leukocytes, cutaneous inflammation and epidermal proliferation.
Seegers BA; Andriessen MP; van Hooijdonk CA; de Bakker ES; van Vlijmen-Willems IM; Parker GL; van Erp PE; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2000; 13(2):75-85. PubMed ID: 10754455
[TBL] [Abstract][Full Text] [Related]
12. An ultrastructural study of transcutaneous migration of polymorphonuclear leukocytes following application of leukotriene B4.
Paulissen M; Peereboom-Stegeman JH; van de Kerkhof PC
Skin Pharmacol; 1990; 3(4):236-47. PubMed ID: 1964566
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene B4-driven neutrophil recruitment to the skin is essential for allergic skin inflammation.
Oyoshi MK; He R; Li Y; Mondal S; Yoon J; Afshar R; Chen M; Lee DM; Luo HR; Luster AD; Cho JS; Miller LS; Larson A; Murphy GF; Geha RS
Immunity; 2012 Oct; 37(4):747-58. PubMed ID: 23063331
[TBL] [Abstract][Full Text] [Related]
14. Production of intraepidermal microabscesses by topical application of leukotriene B4.
Camp R; Jones RR; Brain S; Woollard P; Greaves M
J Invest Dermatol; 1984 Feb; 82(2):202-4. PubMed ID: 6319504
[TBL] [Abstract][Full Text] [Related]
15. Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin.
Lammers AM; van de Kerkhof PC
Br J Dermatol; 1987 Apr; 116(4):521-4. PubMed ID: 3034322
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biochemical effects of an oral leukotriene biosynthesis inhibitor (MK886) in psoriasis.
de Jong EM; van Vlijmen IM; Scholte JC; Buntinx A; Friedman B; Tanaka W; van de Kerkhof PC
Skin Pharmacol; 1991; 4(4):278-85. PubMed ID: 1724166
[TBL] [Abstract][Full Text] [Related]
17. Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4.
Bauer FW; van de Kerkhof PC; Maassen-de Grood RM
Br J Dermatol; 1986 Apr; 114(4):409-12. PubMed ID: 3008801
[TBL] [Abstract][Full Text] [Related]
18. Role of 5-lipoxygenase products in the local accumulation of neutrophils in dermal inflammation in the rabbit.
Marleau S; Fruteau de Laclos B; Sanchez AB; Poubelle PE; Borgeat P
J Immunol; 1999 Sep; 163(6):3449-58. PubMed ID: 10477617
[TBL] [Abstract][Full Text] [Related]
19. Effects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasis.
de Jong EM; Ferrier CM; de Zwart A; Wauben-Penris PJ; Korstanje C; van de Kerkhof PC
J Dermatol Sci; 1995 May; 9(3):185-94. PubMed ID: 8664216
[TBL] [Abstract][Full Text] [Related]
20. The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin.
Wozel G; Chang A; Zultak M; Czarnetzki BM; Happle R; Barth J; van de Kerkhof PC
Arch Dermatol Res; 1991; 283(3):158-61. PubMed ID: 1651071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
